News

Filter

Current filters:

GlaxoSmithKlineBenlysta

151 to 160 of 95986 results

Ablynx receives $2.8 million grant to investigate nanobodies in eye disease treatment

Ablynx receives $2.8 million grant to investigate nanobodies in eye disease treatment

18-08-2014

Belgian drug developer Ablynx has received a 2.1 million euro ($2.8 million) grant from the Flemish Agency…

AblynxBelgiumOphthalmicsPharmaceuticalResearch

Proposal to expand the quality control of medicines sold in Brazil

Proposal to expand the quality control of medicines sold in Brazil

18-08-2014

Brazilian House Bill 6763/13 introduced by Gorete Pereira (PR-EC) sets the standards to ensure the quality…

BrazilPharmaceuticalProductionRegulation

Eisai files for US and EU approval of lenvatinib for hard to treat thyroid cancer

Eisai files for US and EU approval of lenvatinib for hard to treat thyroid cancer

18-08-2014

Japanese pharma major Eisai has filed applications with the US Food and Drug Administration and the European…

DonepezilEisaiEuropelenvatinibOncologyPharmaceuticalRegulationUSA

HUYA to partner with Changzhou Center for Biotech Development to promote local innovation

HUYA to partner with Changzhou Center for Biotech Development to promote local innovation

18-08-2014

Chinese company HUYA Bioscience has announced a partnership with Changzhou Center for Biotech Development,…

BiotechnologyChangzhouChinaHUYA BioscienceResearch

Eisai teams up with Zeria on proton pump inhibitor license agreement

Eisai teams up with Zeria on proton pump inhibitor license agreement

18-08-2014

Japanese drug major Eisai has collaborated with fellow Japanese company Zeria Pharmaceutical to conclude…

EisaiGastro-intestinalsJapanLicensingPharmaceuticalProton pump inhibitorsZeria Pharmaceuticals

Biogen Idec’s Plegridy gains US approval for multiple sclerosis

Biogen Idec’s Plegridy gains US approval for multiple sclerosis

17-08-2014

The US Food and Drug Administration has approved US biotech firm Biogen Idec’s (Nasdaq: BIIB) Plegridy…

Biogen IdecBiotechnologyNeurologicalPlegridyRegulationUSA

IQWiG again turns down Eisai’s epilepsy drug Fycompa

IQWiG again turns down Eisai’s epilepsy drug Fycompa

17-08-2014

The German Institute for Quality and Efficiency in Healthcare (IQWiG) has said that epilepsy drug Fycompa…

EisaiEpilepsyFycompaGermanyNeurologicalPharmaceuticalPricingRegulation

151 to 160 of 95986 results

Back to top